Table 1 Sample collection map of leprosy patients included in this study.

From: Insights into the skin microbiome dynamics of leprosy patients during multi-drug therapy and in healthy individuals from Brazil

*Patients IV M L PT
1 0 6   
2 0 6 12  
3 0    
4 0 5 11 3
5 0 7 11  
6 0 7   2
7 0   10 1
8 0 9   
9 0 8   4
10 0    
11 0    
12   9   5
13 0 8 12 5
14 0 6   
15 0 5 12 4
16 0 6 11 4
17 0   11 5
18 0 7   
19 0    
20 0    
21 0    
22 0 6 12 5
23 0    
24 0    
25 0    
26 0    
27 0 5   
  1. The patients are identified by numbers (1 to 27). The number inside the column indicates the sample month during the study.
  2. IV, initial visit; M, middle-treatment stage (between the 5th and 9th months of multi-drug therapy - MDT); L, late-treatment stage (between the 10th and 12th months of MDT) and PT, post-treatment stage (between the 1st and 5th months following the end of MDT).
  3. *For each patient, samples were taken from non-lesional and lesional sites.